Beta Drugs Ltd.

₹1829.95

Beta Drugs Ltd.

  • NSE : BETA
Add Alert
Add Watchlist

₹1829.95

₹1829.95

14.0 (0.77%) - 3 Oct 2025 04:26 PM
  • NSE : BETA

About Company

Beta Drugs is pharmaceutical formulation manufacturing company engaged in developing, manufacturing and marketing of drug products for domestic and international customers. Beta Drugs is primarily engaged in the manufacturing of oncology products. The products include anti-cancer tablets, capsules, injections and lyophilized injections. Company has portfolio of over 50 products which is used for the treatment of various cancer diseases. Beta Drugs is a part of Adley Group, which was founded in the year 1985. Company's manufacturing unit is located at Solan, Himachal Pradesh.

Market Cap. ₹ 1,833 Cr.
52 Week - High/Low ₹ 0/0
P/E Ratio 49.07
P/B Ratio 15.80
Enterprise Value ₹ 1,821 Cr.
ROE % 20.67
RSI Value 49.65
EMA 50 1824.02
EMA 200 1764.89
Market Cap. ₹ 1,833 Cr.
52 Week - High/Low ₹ 0/0
P/E Ratio 23.25
P/B Ratio 11.67
Enterprise Value ₹ 1,822 Cr.
ROE % 26.03
RSI Value 49.65
EMA 50 1824.02
EMA 200 1764.89

Valuation

Calculators

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Insight market
Copyright © 2025 All rights reserved with INVESMATE INSIGHTS PRIVATE LIMITED | All logos and Trademarks registered with their respective owners.